Team:Washington/BioBricks
From 2014.igem.org
Line 7: | Line 7: | ||
<h1> Submitted Parts </h1> | <h1> Submitted Parts </h1> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/a/a2/Bio-brick_image.jpg" alt="Submitted Biobricks" style="width: | + | <center><img src="https://static.igem.org/mediawiki/2014/a/a2/Bio-brick_image.jpg" alt="Submitted Biobricks" style="width:700px;height:394px"> |
<br> | <br> | ||
<sup><b>Fig 1.</b> Our submitted BioBricks consist of three parts: the Degron, the Gal4-VP16 Transcriptional activator, and Gal4-Degron-VP16 complex.</sup></center> | <sup><b>Fig 1.</b> Our submitted BioBricks consist of three parts: the Degron, the Gal4-VP16 Transcriptional activator, and Gal4-Degron-VP16 complex.</sup></center> |
Revision as of 07:30, 16 October 2014
|
Submitted Parts
Fig 1. Our submitted BioBricks consist of three parts: the Degron, the Gal4-VP16 Transcriptional activator, and Gal4-Degron-VP16 complex.
Degron (BBa_K1408000)
The Degron is an unstable protein domain that, when fused to a protein, acts as a source of instability. The presence of the Degron leads to degradation of the protein by the cell via ubiquitination. This is a new part we are submitting to the registry.
Gal4-VP16 Transcriptional Activator (BBa_K1408001)
This part consists of our Gal4-VP16 fusion protein, which is a transcriptional activator. Gal4 protein binds to a Gal1 promoter, while VP16 recruits transcription machinery, promoting transcription to anything under the Gal1 promoter. The two must be co-localized to work as a transcriptional activator.
This transcrptional activator has been previously submitted to the registry (BBa_K1179014 submitted by the iGEM 2013 MIT team). However, we noticed that this part was incomplete compared to ours and that this part had no user data related to it. In order to make the complete part available, together with experimental data related to the part, we decided to "re-submit" this part to the registry.
Gal4-Degron-VP16 (BBa_K1408002)
This part is a combination of our previous two parts submitted to the registry. By utilizing this system, the relative stabilities of proteins can be compared. A sequence for a protein inserted between the Degron and VP16 will produce a fusion protein which acts as a transcriptional activator for anything under a Gal1 promoter. If the protein inserted is unstable it will be degraded by the cell and the Gal4-VP16 transcriptional activator will no longer function. If a quantifiable marker protein such as Green Fluorescent Protein (GFP) is under Gal1 then the level of GFP output of the cell is related to the stability of the inserted protein.